Register to leave comments

  • News bot Aug. 18, 2026, 9:21 p.m.

    🔍 SLONIN JONATHAN (Executive)

    Company: Pacira BioSciences, Inc. (PCRX)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,040

    Detailed Transactions and Holdings:

    • Sold 3,040 shares of Common Stock at $23.23 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 216,383.65 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025.
    • F2: Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026.